NRx Pharmaceuticals, Inc. (NRXP) vs Tonix Pharmaceuticals Holding Corp. (TNXP)
A side-by-side comparison of NRx Pharmaceuticals, Inc. and Tonix Pharmaceuticals Holding Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NRXP
NRx Pharmaceuticals, Inc.
$2.94HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TNXP
Tonix Pharmaceuticals Holding Corp.
$7.70HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — NRXP vs TNXP
growth of $100 · dividends reinvested · last 9yNRXP -97.0% (-32.3%/yr)TNXP -100.0% (-81.5%/yr)NRXP compounded faster over this window
Log scale — wide-divergence pair
NRXP TNXP
NRXP vs TNXP: by the numbers
- •NRXP is the larger company ($127M vs $123M market cap).
- •Both run net losses; TNXP's is the smaller (-548.64% vs -691.81% net margin).
Metrics side by side
Valuation
| Metric | NRXP | TNXP |
|---|---|---|
| P/S ratio | 37.50 | 4.21 |
| P/B ratio | N/A | 0.55 |
Profitability
| Metric | NRXP | TNXP |
|---|---|---|
| Gross margin | 58.78% | 34.65% |
| Operating margin | -1324.41% | -959.05% |
| Net margin | -691.81% | -548.64% |
| ROE | N/A | -71.83% |
| ROIC | N/A | -74.08% |
Growth (annualized)
| Metric | NRXP | TNXP |
|---|---|---|
| Total return CAGR (5Y) | -49.61% | -87.55% |
Frequently asked
- How have NRXP and TNXP total returns compared?
- Over the past 5 years, NRXP delivered -49.61% and TNXP delivered -87.55% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.